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Background: Ulcerative colitis (UC) is a chronic, inflammatory bowel disease which may lead to dysplasia and
adenocarcinoma in patients when long-lasting. Short telomeres have been reported in mucosal cells of UC patients.
Telomeres are repetitive base sequences capping the ends of linear chromosomes, and protect them from erosion
and subsequent wrongful recombination and end-to-end joining during cell division. Short telomeres are associated
with the development of chromosomal instability and aneuploidy, the latter being risk factors for development of
dysplasia and cancer. Specifically, the abrupt shortening of one or more telomeres to a critical length, rather than
bulk shortening of telomeres, seems to be associated with chromosomal instability.
Methods: We investigated possible associations between dysplasia, aneuploidy and telomere status in a total of
eight lesions from each of ten progressors and four nonprogressors suffering from longstanding UC. We have
analyzed mean telomere length by qPCR, as well as the amount of ultra-short telomeres by the Universal STELA
method.
Results: An increased amount of ultra-short telomeres, as well as general shortening of mean telomere length are
significantly associated with dysplasia in longstanding UC. Furthermore, levels of ultra-short telomeres are also
significantly increased in progressors (colons harbouring cancer/dysplasia and/or aneuploidy) compared to
nonprogressors (without cancer/dysplasia/aneuploidy), whereas general shortening of telomeres did not show
such associations.
Conclusions: Our data suggest that ultra-short telomeres may be more tightly linked to colorectal carcinogenesis
through development of dysplasia in UC than general telomere shortening. Telomere status was not seen to
associate with DNA aneuploidy.
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Telomeres are specialized structures capping all linear
chromosomes, thereby protecting them from erosion
during cell division and from wrongful recombination
and end-to-end joining [1]. In cancer development telo-
meres have shown to play a dual role: when cell cycle
checkpoints are intact they will act as a tumour suppres-
sor mechanism by bringing about cellular senescence or* Correspondence: mariann.friis-ottessen@rr-research.no
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distribution, and reproduction in any mediumapoptosis when the telomeres are too short for further
division. If however, cell cycle checkpoints are disabled,
cells are able to keep dividing past this point and pos-
sibly engage in development of chromosomal instability
(CIN) [2,3]. It has previously been shown that human
cancer cells may harbour ultra-short telomeres [4], and
current beliefs are that it is not the shortening of the
mean telomere length that might contribute to the
development of CIN and altered morphology, but one or
a few telomeres shortened to an “ultra-short” state [5,6]
These ultra-short telomeres are suspected to form from
an abrupt loss of a larger part of a telomere. Oxidative
stress is known to cause single strand breaks in DNAentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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chromosome are often not repaired, thus leaving the cell
with a shortened telomere after genome duplication [8].
Few options for measurement of the amount of ultra-
short telomeres are available. Methods for detecting the
shorter telomeres, like Q-FISH methods, are generally
limited by the need for viable cells, or that they detect
the percentage of cells containing short telomeres within
a population. They are not able to detect a single, short
telomere within a population [9,10]. In 2003, Baird and
colleagues presented the single telomere length analysis,
STELA, that is able to detect the shortest telomeres in a
sample [11]. This analysis was originally limited to the
XpYp telomeres, but has since been extended to several
autosomal chromosomes as well [12]. This method de-
tects chromosomes where the subtelomeric region is
known, as it is dependent upon a chromosome-specific
proximal primer. Bendix and colleagues then presented a
method in 2010 that provides an estimate of the load of
ultra-short telomeres in a DNA sample. This method is a
version of the STELA, and was named the Universal-
STELA, as it is not limited to chromosomes with known
subtelomeric composition [13].
Ulcerative colitis (UC) is an inflammatory bowel dis-
ease characterized by inflammation-induced chronic de-
struction and regeneration of colonic mucosa, resulting
in dysplasia and cancer development in some patients.
Patients with long lasting UC are at increased risk for
development of adenocarcinomas, usually following mu-
cosal transition to dysplasia [14]. It is estimated that 10%
of patients suffering from long-term UC will develop
preneoplastic changes that might lead to cancer. These
patients can be characterized as progressors, as they
have preneoplastic changes in one or more locations that
are associated with increased risk of progression to inva-
sive cancer. A progressor is typically defined as a patient
with dysplasia or cancer. We have also included detec-
tion of DNA-aneuploid cell populations as a trait of a
progressor colon. A patient not presenting cancer, dys-
plasia or aneuploid cell populations will thus be consid-
ered a nonprogressor using these criteria.
Patients suffering from UC have been shown to
harbour shorter telomeres in their colonic mucosa com-
pared to age-matched controls [15-17]. UC-progressors
harbour shorter telomeres than do UC-nonprogressors
[18] and it has been shown that the mean telomere
length of a UC-colon is mainly shortened during the first
eight years following onset of the disease [17]. Differ-
ences in mean telomere length between low-grade dys-
plasia (LGD) and high-grade dysplasia (HGD) in the
colonic mucosa of patients suffering from long-term
UC, with the shortest telomeres reported from mucosa
with LGD, have recently been reported [16]. DNA aneu-
ploidy has also been associated with the development ofmalignancy in UC patients [19-21], and it has been
shown that DNA aneuploidy is present in dysplastic as
well as non-dysplastic areas of colonic mucosa [21-23].
Thus, both mucosal dysplasia [24,25] as well as DNA
aneuploidy [21,26] might predict increased risk for pro-
gression to adenocarcinomas in the colon of patients
with longstanding UC. Our aim was to examine telo-
mere biology in preneoplastic lesions of patients with
longstanding UC. Using the recently developed method,
U-STELA, we investigated possible differences in the
amount of ultra-short telomeres in aneuploid and diploid
dysplastic and non-dysplastic lesions from UC-progressor
colectomies. Nonprogressor UC-colons served as controls.
Methods
Histopathology
We examined colectomy specimens from 14 patients
with longstanding UC from 10–30 years, resected at the
Department of Surgery, Rikshospitalet, in the period
1985–1994. The colectomies are part of a patient mater-
ial that has previously been investigated for aneuploidy-
related parameters by our research group [27]. The material
included 3 females and 11 males. All but 3 developed UC
before the age of 50, and all patients presented extensive
colitis.
Use of this material for research purposes has ethical
approval from the Regional Ethical Committee, REK
S-06062.
10 patients were classified as UC-progressors, i.e. pre-
sented with one or more areas of dysplasia or aneuploidy
in their colonic mucosa. Tissue specimens for histo-
pathological evaluation were harvested from eight con-
secutive locations throughout each bowel, in addition to
samples collected from gross lesions if present. A total
of 78 lesions were available for analysis and fixed in 70%
ethanol and embedded in paraffin. Some of the speci-
mens were fixed in formalin only. Tissue sections were
cut at 4 μm thickness, stained with hematoxylin-eosin
and evaluated independently by two experienced pathol-
ogists (OPFC, SNA) according to Riddell et al. [28]. The
mucosal morphology was classified independently by
each pathologist, and if the evaluation was the same, this
diagnosis was used, if not, the lesions were viewed
through a double microscope and discussed until con-
sensus was reached. A portion of each fresh tissue speci-
men was used for isolation of single cells for DNA flow
cytometry and for DNA extraction for molecular genetic
analysis (see below). Biopsies from 4 colectomies classi-
fied as nonprogressor UC-colons were used as controls.
DNA-flow cytometry
Mucosa adjacent to that used for histopathological
examination was mechanically disaggregated in PBS and
EDTA using a scalpel. The resulting cell suspensions
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at 1500 RPM for 5 minutes. The resulting pellet was
resuspended in 1 ml PBS and fixed in 70% ice-cold Etha-
nol. Samples were stored overnight before preparation
for DNA analysis using the procedure of Vindeløv [29],
and were analyzed using a FACStar Plus cytometer
equipped with 488 nm argon ion laser (BDIS, Spectra
Physics, Mountain View, CA, USA). DNA content was
assessed based on propidium iodide (PI) fluorescence
emission. Aggregates and doublets were excluded from
analyses using red fluorescence pulse width of the PI-
signal. The purity of epithelial cells in the cell suspensions
were analysed by bivariate forward scatter/PI fluorescence
[30] and bivariate cytokeratin/PI fluorescence [31] and
estimated to be >80%.
The amount of ultra-short telomeres measured by U-STELA
The Universal STELA method was performed as de-
scribed by Bendix and colleagues [13], with a few minor
alterations. Fifty ng DNA, extracted from each of the 78
lesions, was digested using a 1:1 mix of restriction
enzymes NdeI and MseI. Ten ng of digested DNA was
mixed with 50 μmol of the oligoes 42-mer and 11 + 2-
mer. The mix was ramped from 65°C to 16°C over one
hour, before adding 20U T4 ligase together with 1x NEB
buffer 2 and 1x ATP (NEB). This mixture was left at
16°C for 12 hours before 20 U t4 ligase together with
10-3 μM telorette 3, 1x ATP and 1x NEB buffer 2 was added
(to a total volume of 25 μl). The mixture was kept for 12
hours at 35°C, followed by a 20 minutes inactivating step
at 65°C. PCR was then performed in a 12 μl reaction
containing 40 pg template, 1x Failsafe PCR premix H
(Epicentre), 0, 1 μM of each of primers Teltail and
Adapter, and 1,25U Failsafe Enzyme mix (Epicentre).
The reactions were performed on a 2720 Thermal Cycler
(Applied Biosystems) with the conditions one cycle of
68°C for 5 minutes and 95°C for 2 minutes, followed by
24 cycles of 95°C for 15 seconds, 58°C for 20 seconds
and 72°C for 11 minutes, and one cycle of 72°C for 15
minutes. The PCR-products were separated on a 0, 85%
TBE Seakem agarose gel at 5 V/cm, and transferred to a
positively charged nylon membrane by Southern blotting
using a vacuum blotter. The blotted DNA was then hy-
bridized overnight to a digoxigenin (DIG)-labelled probe
specific for the telomeric sequence and further incu-
bated with a DIG-specific antibody coupled to alkaline
phosphatase (Roche). The probe was visualised by CDP-
Star, a chemiluminescent substrate (Roche) and detected
using a Kodak Image Station 4000R. The fragment sizes
of the PCR-products are determined based on a DIG-
labelled molecular weight marker (Roche), using Mole-
cular Imaging from Carestream. A cut-off was set at
900 bp, as normal colonic mucosa had very few bands using
this threshold (data not shown), and in UC-samples thebands were presented as single, separated bands. Bands
were counted manually. An illustration of U-STELA results
is shown in Figure 1.
Mean telomere length analysis
Telomere mean length quantification was carried out
with an adaptation of the Q-PCR methods described by
Cawthon [32,33]. TaqMan Copy Number Reference
Assay RNase P (located at 14q11.2 ) or alternatively Taq-
Man Copy Number Reference Assay Tert (located on
5p5.33 ) (Both Applied Biosystems, Denmark) was run
at recommended conditions to measure the single copy
gene copy number (SCG). For measurement of telomere
repeat copies (T) primers telg – 5′-ACA CTA AGG
TTT GGG TTT GGG TTT GGG TTT GGG TTA GTG
T-3′ and telc – 5′-TGT TAG GTA TCC CTA TCC CTA
TCC CTA TCC CTA TCC CTA ACA-3′, [32] were
added at a concentration of 0.5 μM to Ssofast EvaGreen
Supermix with low ROX (BioRad, Denmark). Cycling
conditions were: 2 min at 50°C, 2 min of 95°C, followed
by 2 cycles of 95°C for 15 s, 52°C for 15 s and 36 cycles
of 95°C for 15 s, 62°C for 15 s and 71°C for 15 s. The
PCR was run on a 7900HT Fast Real-Time PCR System,
as presented by Bendix and colleagues [34]. Following
amplification, telomeric to single copy gene (T/SCG)
ratios were derived from a standard curve using the
7900HT Sequence Detection System version SDS2.3
(Applied Biosystems, Denmark). The results were pre-
sented as T/SCG ratios. Samples were run twice in tripli-
cates and the mean of these runs was used. Average
coefficient of variance (CV) for T/SCG using RNAse P
was 10.5%. Average CV for T/SCG using TERT was
11.3%.
We have used two different primer sets for SCG be-
cause the mean length is derived from the ratio between
telomere product and single copy gene-product, and
therefore there is a potential risk that we will either
over- or underestimate the telomere length of the lesions
comprised of aneuploid cells if the chosen SCG should
be duplicated or deleted in these cells. TERT was chosen
to supplement the RNAseP. TERT is located on
chromosome 5p, a region often amplified in aneuploid,
sporadic colorectal cancers [35] as well as in aneuploid
UC [36]. By comparing the T/SCG-ratios derived from
the aneuploid lesions alone, we note correlation in all
but six lesions, four of which are adenocarcinomas
(Additional file 1). To further overcome this potential
limitation we repeated statistical analysis with only diploid
lesions (presented in Additional file 2). Based on these
results RNAse P was selected as SCG for our analyses.
Statistics
The relationships between mean telomere length/
amounts of ultra short telomeres and morphological
Figure 1 The Universal STELA. Excerpts of two typical membranes generated by a Southern blot, visualizing the ultra-short telomeres as
analysed by the Universal STELA. Each lane represents a PCR-reaction. Eight separate PCR-reactions are performed for each lesion analysed. The
horizontal bar marks 900 basepairs. Bands below this bar represent single telomeres and are counted for the analyses. A) Two lesions from a
nonprogressor. B) Two lesions from a progressor.
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parametric t-tests and one-way ANOVA and the multi-
variable, general linear model (GLM). To address the
possible differences generated by natural variation be-
tween patients we also utilized a mixed model analysis
that took into account that each patient generated mul-
tiple lesions. Tests were performed in PASW statistics
18 (Chicago, Illinois) and in GraphPad Prism (San Diego,
California). All tests were two-sided and a p-level of 0.05
denoted significance.
P-values from t-tests, including the Universal-STELA
and both SCG primers tested for measuring mean
telomere length are listed in Additional file 2.Results
Histopathology
From the analyzed 14 colectomies 10 colons revealed at
least one area with dysplasia, adenocarcinoma or DNA
aneuploidy out of the eight areas analyzed (see Table 1).
Within the same lesion the mucosal morphology might
differ; in such cases the highest degree of abnormality
was registered. Of the 78 areas analyzed, 40 areas did
not show dysplasia (51.3%), 15 areas were considered
indefinite for dysplasia (19.2%), 17 areas had either low
or high grade dysplasia (21.8%) and 6 adenocarcinomas
(7.7%) were found. These ten colectomy specimens were
therefore considered progressors, including one bowel
with 4 areas indefinite for dysplasia and four non-dysplastic areas. Two lesions were not available for ana-
lyses. Four colectomies presented only diploid, non-
dysplastic lesions. These were classified as nonprogressors
and used as controls.
Due to limited amounts of DNA from some colectomy-
samples only one of the methods could be performed on
some of the cases (see Table 2).DNA flow cytometry
The DNA ploidy status of the colectomies has been previ-
ously assessed [27]. Within the 10 progressor colons ana-
lyzed 57 lesions were diploid (70%) and 21 (30%) lesions
harboured aneuploid populations (see Table 1). In addition
one diploid and five aneuploid adenocarcinomas were
recorded. Two lesions were not available for analyses. We
detected both aneuploid and diploid non-dysplastic areas
as well as aneuploid and diploid dysplastic areas. One
colon was diploid all through, but presented multiple sites
of dysplasia. All nonprogressor lesions were diploid.
The proportion of aneuploid cells varied from around
5% to 10% within the lesions presenting aneuploid cell
populations, with exception of one case (S169) presenting
aneuploid cell counts estimated to be between 15 and 50%
and one cancer (S99) represented only in qPCR.Ultra-short telomeres and associations
Overall we found a significant difference in the amount of
ultra short telomeres between progressor and nonprogressor
Table 1 UC-patient materials
Sample ID Aneuploid
areas
Dysplasia Adeno-
carcinoma
Universal
STELA
qPCR
No Indefinite Low-grade High-grade
Nonprogressors
S9 0 8 0 0 0 0 X X
S48 0 8 0 0 0 0 X X
S62 0 8 0 0 0 0 X X
S216 0 7 0 0 0 0 X
Total 31
Progressors
S30 1 7 0 0 0 1 X
S70 0 6 0 0 1 1 X X
S99 2 0 2 2 3 1 X
S132 3 1 5 2 0 0 X X
S159 3 2 0 3 1 0 X
S169 6 1 1 2 1 3 X X
S191 3 6 1 1 0 0 X
S199 1 5 1 1 0 0 X X
C1514 2 7 1 0 0 0 X X
C1729 0 4 4 0 0 0 X X
Total 21 39 15 11 6 6
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when comparisons are restricted to diploid, non-dysplastic
lesions of the progressors (see Additional file 2).
Within the progressors we defined four morphological
parameters; non-dysplasia, indefinite for dysplasia, dys-
plasia and adenocarcinoma. Dysplasia comprises both
high-grade and low-grade dysplasia, due to few dysplas-
tic lesions and no statistical significant difference in the
amount of ultra short telomeres detected between the
two groups (p = 0.534).
Dividing the dysplastic lesions as mentioned previ-
ously, we noted a significant increase in the amount of
ultra-short telomeres in areas indefinite for dysplasia
when compared to non-dysplastic lesions (p = 0.003).Table 2 Lesions available for telomere analyses
Aneuploid lesions Diploid lesions
U-STELA qPCR U-STELA qPCR
Nonprogressor lesions
Non-dysplasia 0 0 27 22
Dysplasia 0 0 0 0
Total 0 0 27 22
Progressor lesions
Non-dysplasia 4 7 24 25
Dysplasia 8 13 15 24
Total 12 20 39 49The amount of ultra short telomeres detected in lesions
indefinite for dysplasia did not differ significantly from
amounts detected in dysplastic lesions or to the adeno-
carcinomas (ANOVA with Bonferroni post hoc test)
(Figure 2A). No significant difference in the levels of
ultra short telomeres was detected between lesions with
and without aneuploid populations. Within the diploid
lesions of the progressors we found significantly raised
levels of ultra short telomeres in the dysplastic lesions
compared to the non-dysplastic lesions (p = 0.014),
whereas no significant difference was detected between
the aneuploid dysplastic areas compared to aneuploid
non-dysplastic areas, and diploid dysplasia did not differ
from aneuploid dysplasia.
Significant differences related to the location within
the colon were not observed. Within the progressor
colons we detected a trend towards elevated number of
ultra short telomeres in the dysplastic lesions (indefinite
for dysplasia and/or dysplasia) compared to the non-
dysplastic lesions of the same colon. No such trend was
detected when comparing diploid and aneuploid lesions
with respect to the amount of ultra short telomeres,
within a colon.
To further test if the amount of ultra short telomeres
can be an independent predictor of dysplasia in progres-
sor colons we built a model that included morphology,
DNA ploidy status, duration of disease combined with
onset of UC and location of the biopsy within the colon.
Figure 2 Ultra-short telomeres and mean telomere length in nonprogressors and progressors. A) The amount of ultra short telomeres
differs significantly from nonprogressors to progressors (p < 0.001). Within progressors there is a significant rise in the amount of ultra short
telomeres in lesions indefinite for dysplasia compared to non-dysplastic lesions. No difference is seen within the different degrees of dysplasia
and adenocarcinoma. B) No significant difference was detected in mean telomere length from nonprogressors to progressors. Within the
progressors we noted a significant shortening in mean telomere length in lesions indefinite for dysplasia and in adenocarcinomas from
non-dysplastic lesions. (ANOVA with Bonferroni post hoc test).
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model (multivariable GLM). The results of this test
supported our findings of ultra short telomeres being a
possible predictor of dysplasia in progressors (p = 0.007)
even when the other parameters are taken into account.
As all colectomies contributed eight lesions to our
analyses we also performed a mixed model analysis that
considers the natural variation between each patient. Still
we found a significant difference between progressor and
nonprogressor cases (p = 0.014). Within the ten progressorcolectomies we found a significant difference between the
different degrees of dysplasia when LGD, HGD and adeno-
carcinomas were combined (p = 0.033). No significant dif-
ference was seen comparing diploid and aneuploid lesions.
Other parameters tested were patients’ age at onset of
disease, and duration of disease, as our patient material
varied greatly with respect to both parameters. No associ-
ation between the amount of ultra-short telomeres and
either of these parameters was seen (data not shown). Gender
did not associate with the amount of ultra-short telomeres.
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In this analysis we did not find any difference in mean
telomere length between progressors and nonprogres-
sors, neither in the whole material, nor when analy-
sing only non-dysplastic, diploid lesions (Figure 2B and
Additional file 2).
Within the progressors a significant shortening in
mean telomere length was seen when comparing a group
comprising lesions indefinite for dysplasia and dysplasia,
to non-dysplastic lesions of the progressors-colons (p =
0.002) (see Additional file 2).
This remained significant also when restricting the ana-
lysis to diploid lesions alone (p = 0.008). No significant
difference in mean telomere length was found comparing
indefinite for dysplasia, dysplasia and adenocarcinoma,
but we noted a significant reduction in mean telomere
length for lesions indefinite for dysplasia as well as
for adenocarcinomas compared to the non-dysplastic le-
sions of the progressors (ANOVA p = 0.003; Bonferroni
post hoc test, p = 0.039 and p = 0.027, respectively)
(Figure 2B).
Between the segments of the colectomies we found
within the progressors a significant reduction of mean
telomere length in the transverse colon compared to the
ascending colon (ANOVA, Bonferroni post hoc test, p =
0.011). The descending part of the colectomies did not
differ from either the transverse or the ascending colon.
No significant difference was detected between the
non-dysplastic and dysplastic aneuploid lesions, or be-
tween diploid and aneuploid dysplasia. When comparing
different lesions within each progressor colon we de-
tected a trend towards reduced mean telomere length in
dysplastic versus non-dysplastic lesions within colons.
No such trend was seen between diploid and aneuploid
lesions of the colons.
We repeated the calculations with the mean length
normalized to TERT. The findings were overall similar
to those registered when normalizing to RNaseP, but
difference between progressors/nonprogressors was now
borderline significant (p = 0.08), and the difference in
mean telomere length between diploid and aneuploid
lesions within the progressors was statistically significant
(p = 0.04) (see Additional file 2).
In a multivariable GLM where we tested for the effect
of biopsy location, degree of dysplasia, DNA ploidy sta-
tus and age at onset combined with duration of UC, we
found that in the progressor colectomies, both location
of the biopsy (p =0.006) and degree of dysplasia (p =
0.012) might be individually influential to the mean
telomere length.
Since each colectomy provided several lesions we per-
formed a GLM considering the patient variations. No sig-
nificant difference was found when comparing progressor
colectomies to nonprogressor colectomies. Within theprogressor cases there was a significantly longer mean
telomere length in non-dysplastic compared to dysplastic
lesions when dysplastic lesions contained all dysplasia
(indefinite, LGD, HGD and adenocarcinoma) (p = 0.028).
The significance disappeared when lesions indefinite for
dysplasia was viewed as a separate group.
Mean telomere length did not associate with gender,
patients’ age at disease onset or to duration of UC.
Discussion
It has been suggested that it is not necessarily the gen-
eral shortening of telomeres that causes chromosomal
instability and aneuploidy, but rather one or more critic-
ally short telomeres [5]. We have examined the amount
of ultra-short telomeres [13] in the colonic mucosal cells
of patients suffering from long standing UC, who have
developed dysplasia and/or DNA-aneuploidy. We com-
pared these findings with those from patients suffering
from long standing UC without displaying dysplasia or
DNA-aneuploidy. Patients with long standing UC have
previously been reported to exhibit shortening of mean
telomere length in their colonic mucosa, but the amount
of ultra-short telomeres has so far not been investigated.
One major finding is a highly significant increase in
number of ultra-short telomeres in progressor colons
compared to nonprogressor colons, both when including
all lesions of the progressors as well as when restricting
the progressor lesions to non-dysplastic, diploid lesions
only. Furthermore, both simple pair-wise comparisons
and multivariate analysis showed that the degree of
increase in ultra-short telomeres associated much better
with degree of dysplasia than with ploidy status, disease
duration or location. This was seen whether we included
the adenocarcinomas in the dysplasias, or not. In con-
trast; there was no difference in mean telomere length
between nonprogressors and progressors, although we
also here found an association of mean telomere length
with dysplasia. The fact that the number of ultra-short
telomeres was significantly higher in dysplastic areas
compared to non-dysplastic areas suggests that the oc-
currence of ultra-short telomeres is an early event in the
progression towards dysplasia and invasive cancer. This
is further supported by the fact that the lesions defined
as indefinite for dysplasia, which applies to epithelial
changes that exceed the limit for regeneration but are
insufficient for an unequivocal diagnosis of dysplasia
[28], have significantly more ultra-short telomeres than
non-dysplastic mucosa. Elevated numbers of ultra-short
telomeres in dysplastic compared to nondysplastic areas
were also seen comparing dysplastic to the non-dysplastic
lesions using a mixed model analysis. The mixed model
analysis compensates for inter-patient differences, and
gives a strong indication that the differences seen are in-
deed caused by differences in the mucosal morphology.
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not seen between diploid and aneuploid lesions within the
examined colectomies, when examined by the mixed
model analysis.
Thus; increased numbers of ultra-short telomeres may
be a marker of UC-colons harbouring dysplasia, cancer
and/or aneuploidy, but may also just predict the future
development of these conditions.
Short telomeres predispose to end-to-end fusions of
chromatids, ultimately leading to chromosome breaks
and chromosome losses [18,37]. We did not find any as-
sociations between the amount of ultra-short telomeres
and aneuploidy. However; it has been previously shown,
and confirmed by our results, that not all dysplasias are
aneuploid. Aneuploidy develops in non-dysplastic as well
as dysplastic mucosa [19,23], and associations between
dysplasia and ploidy status respectively, to telomere
shortening, may be different. We did not detect any sta-
tistically significant difference when comparing aneu-
ploid progressor lesions to diploid progressor lesions,
and diploid dysplasia did not differ from aneuploid
dysplasia, further indicating that DNA aneuploidy is not
strongly associated with elevated levels of ultra-short
telomeres. However, we have analysed areas of UC-
colons that had developed DNA-aneuploidy, and most
lesions included a rather low amount of aneuploid cells
(see Result section; DNA flow cytometry for details). We
can therefore not exclude an association between aneu-
ploid cells and ultra-short telomeres. To investigate this
problem, pure populations of sorted aneuploid cells
should be analyzed.
We find that dysplastic lesions in longstanding UC
have significantly shorter mean telomere length com-
pared to non-dysplastic areas, when we combine lesions
indefinite for dysplasia and dysplastic lesions. This holds
true also when separating lesions indefinite for dysplasia
from dysplastic lesions: both parameters had signifi-
cantly reduced mean telomere length compared to non-
dysplastic lesions, but no difference was seen between
lesions indefinite for dysplasia and the dysplastic lesions.
This was seen whether we included adenocarcinomas in
the dysplastic lesions or excluded them from the data
completely, but not when adenocarcinoma was also in-
cluded in the statistics as a separate group. The adenocar-
cinomas presented significantly shorter mean telomere
length than seen in non-dysplastic lesions, whereas both
indefinite for dysplasia and dysplastic lesion had no statis-
tical significant difference in mean telomere length from
non-dysplastic lesions. These results indicate a gradual
shortening from areas indefinite for dysplasia through dys-
plasia to adenocarcinoma. Considered together with the
results from the amount of ultra-short telomeres discussed
above, our results seem to illustrate damage to telomeres
by oxidative stress in the colonic mucosa of UC-patients,as oxidative stress may cause shortening of mean telomere
length as well as an abrupt shortening of a single or of a
few telomeres.
Shortening of mean telomere length in non-dysplastic
mucosa of UC patients has previously been shown, and
was also reported to be associated with chromosomal in-
stability [18]. Shortened mean telomere length of the co-
lonic mucosa has also been reported in association with
development of colorectal cancer in patients suffering
from UC [16,17]. Other parameters that have been
found to associate with such development are morpho-
logical changes and development of DNA-aneuploidy
[16,17,19,21,26,37,38]. Furthermore, it has been reported
that patients suffering from UC have generally shorter
mean telomere length in their colonic mucosa compared
to non-UC control patients. The location of the biopsies
within the bowel did not affect these results, and there
are indications that the main shortening of telomeric
length occurred during the initial eight years of disease
[15-18]. It has also been shown by others that progres-
sors have generally shorter telomeres than registered in
nonprogressors [18]. The patients in the present study
have suffered from UC from a minimum of 10 years,
some as long as 30 years, and the mean telomere length
in their colonic mucosa may therefore be reduced too
much to detect possible differences between nonprogres-
sors and progressors. This may be an explanation to the
finding of no significant difference in mean telomere
length between progressors and nonprogressors in our
study. Another possible explanation might be that we
have a rather small number of patients coupled with a
rather high coefficient of variation for mean telomere
length measurement with either of the single control
genes used (10.5% and 11.3%).
In a recent report it was shown that patients develop-
ing UC after the age of 50 present longer telomeres than
patients developing UC at an earlier age [39]. In our ma-
terial only two progressor cases and one nonprogressor
case had reached the age of 50 before reporting signs of
UC, and none of them differed from the rest of the pro-
gressor cases with respect to mean telomere length or to
the amount of ultra-short telomeres. A possible explan-
ation for the lack of differences detected between these
groups might also be severity of disease, as all patients
included in our study had developed pancolitis before
colectomy.
The difference we noted in the two SCGs used to estimate
mean telomere length might be caused by amplification of
chromosome arm 5p, the arm that contains the h-TERT
locus. Amplification of 5p is often seen both in aneuploid,
sporadic colorectal cancers [35] and even more frequently
in aneuploid UC [36]. Duplication of h-TERT in some of
the aneuploid lesions can report a too low T/SCG value in
these samples, and lower the mean value of the combined
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difference in mean telomere length between the diploid and
aneuploid populations, than what is actually the case, and
ultimately lead to a false statistical significance. We therefore
considered RNaseP to be a more accurate SCG for this
analysis.
Expression of hTERT is considered the limiting factor
of telomerase assembly, and thus of telomerase activity.
The presence of hTERT elevation in UC with mild
inflammation [40] could perhaps be a protective agent
against development of ultra-short telomeres within
nonprogressors.
An important finding in the present communication is
that the telomere related abnormalities in mucosa from
patients with long-standing UC are much less significant
when measuring mean telomere length than when meas-
uring number of ultra-short telomeres. This finding sug-
gests that the mechanism behind telomere pathology is
not only increased replication due to cell renewal, since
this would have resulted in a decrease in mean telomere
length. In contrast it has been shown in a model system
[41], that stochastic telomere breaks resulting in an
increase in number of ultra-short telomeres without
concomitant decrease in mean telomere length can be
the result of severe oxidative damage to telomeres. Our
findings could suggest that oxidative damage is a major
reason for telomere pathology in UC mucosa, a hypothesis
that is supported by the finding of elevated levels of
oxidative stress in the mucosa of UC patients [42,43].
To what extend the high frequency of ultra-short telo-
meres in colon mucosa cells of patients with UC have
causal relationship with increased risk of UC-related colon
cancer in these patients is still unknown. A carcinogenic
pathway from short telomeres linked to breakage-fusion-
bridge cycles to development of chromosome aberrations
and aneuploidy, and ultimately to malignant transform-
ation, has been indicated previously in a model system [44].Conclusion
We have confirmed that mean telomere length is re-
duced in dysplastic colonic mucosa in progressor colons
of longstanding UC compared to non-dysplastic mucosa,
and shown that the amount of ultra-short telomeres is
increased in the same situation. Furthermore, we have
shown that the amount of ultra-short telomeres is
significantly increased in colonic mucosa of progressors
compared to nonprogressors, whereas such a difference
was not found with respect to mean telomere length.
This suggests that ultra-short telomeres are a more sen-
sitive marker of tumour progression than mean telomere
length in longstanding UC, and also that the Universal-
STELA may be a more accurate estimator of a progres-
sor than qPCR and mean telomere length measurement.Additional files
Additional file 1: Mean telomere length estimated with two
different single copy genes (SCG). The relation between mean
telomere estimated with the regular SCG RNAseP (TS_RNAseP) and
the mean telomere length with the alternative TERT gene (TS_TERT).
There is correlation in all samples but six (marked with arrows). These
six samples are from progressors and all are aneuploid. Of the six lesions
four were adenocarcinomas, one was dysplastic and one was a
non-dysplastic lesion.
Additional file 2: Mean and p-values from t-tests. Mean values and
p-values of t-tests comparing progressors to nonprogressors, and
comparing the different parameters from the progressor colons. Results
are reported for U-STELA and for two different mean telomere analyses.
One was using RNAseP as SCG, the other using TERT.
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